Submitted by Anonymous (not verified) on 7 October 2025 - 16:00
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 39, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 39, Status: Authorised